Sorry, but I just couldn’t bring myself to schlepping out yet another Valentine’s Day edition of Health Wonk Review. And though there was some inspiration for a Super Bowl-themed edition (read on), that too, seemed just a little too easy.
But it seemed pretty obvious that most of our Health Wonk Review contributors this week were seeing dollar signs and thus, my theme. (Yes, money is probably a fitting theme for most editions, but hey, let’s go with it anyway.)
The rich execs get richer
We might as well start off with Roy Poses over at Health Care Renewal, who’s seeing red over the abundance of greenbacks going to executives at Carolinas Healthcare. In The Rich (Hospital Managers) Get Richer – Carolinas Healthcare Raises Executive Compensation Once Again, Poses wasn’t mincing words about the fact that the rich at CH just continue to get richer:
Every year it is justified by the same tired talking points: executive pay is dictated by a “free market,” health care management is a particularly difficult job, much more difficult than taking care of patients, and health care managers are brilliant. And every year there are examples that these particular managers are not so brilliant. Where are the echoes, and where is the outrage? As long as top health care leaders can pay themselves so splendidly and with so little accountability, health care dysfunction will continue.
Money down the Super Drain?
Joe Paduda vented about wild sums of money this week, too, in The Super Bowl of Drugs (that Super Bowl tie-in I mentioned). Paduda tuned into Super Bowl 50 only to be turned off by a bunch of high-dollar commercials about pharmaceuticals.
“If you weren’t nauseated by the animated digestive tracts and frequent allusions to digestive disorders, the market forces allowing pharma to spend $10 million on an ad for toenail fungus should make you ill indeed,” Joe commented.
About that $1.4 trillion price tag …
And speaking of money – and lots of it – Charles Gaba took a look at Bernie Sanders’ $1.4 trillion (he predicts) Single Payer plan in How close can we get to zero percent uninsured?
Gaba’s question: Do we really need to spend that kind of money to move the U.S. nearer to universal coverage? (Check out the post if you’re interested in Gaba’s point-by-point plan for moving the needle.)
Are we under-compensating?
We’ve got two great posts on the topic of employee compensation this week:
- Over at Workers Comp Insider, Tom Lynch looks at Fifty States, Fifty Different Laws: A Peter Rousmaniere Analysis. Lynch says this important new report on “the uncompensated worker” examines the growing flaws and shortcomings of the workers comp system and the way that it is failing the American worker.
- On Health Affairs Blog, Joseph Antos and James Capretta discuss two recent Health Affairs studies and argue that it is too soon to conclude that the Affordable Care Act (ACA) will not reduce hours worked or total compensation, as predicted by the Congressional Budget Office. In a further analysis of the studies, the authors write:
“These studies provide useful new information, but they do not mean, as some reporting on them seems to suggest, that there is nothing to worry about with respect to the ACA’s effects on labor markets. Given the structure of the ACA, it would be hard to conclude the law would not eventually reduce hours worked or total compensation, although the magnitude of the resulting changes may be hard to detect in the U.S.’s large and complex labor markets.”
- On a directly related note –Health Affairs Blog contributors Bowen Garrett and Robert Kaestner discuss the same recent Health Affairs studies in Claims That The ACA Would Be A Job Killer Are Not Substantiated By Research. They write that the ACA has had little if any, adverse effect on employment.
Based on the existing body of evidence, the authors note that “the ACA has increased health insurance coverage for many millions of Americans with no reduction in overall employment; the ACA’s Medicaid expansions have had no discernable adverse effects on employment patterns; and more study is needed on the effects of the ACA on part-time work, but the current weight of the evidence leans towards small effects so far.
Providers becoming payers
Did you know that most new Medicare Advantage plans are sponsored by health care providers? At Health Business Blog, David Williams explains why that’s happening – and what it all means – in his post, In Medicare Advantage providers are becoming payers.
The dreaded fees
This week’s post from Louise Norris – Senate Bill 2 and Connect for Health Colorado’s Administrative Fee – looks at SB2, Colorado legislation that “calls out Connect for Health Colorado’s administrative fee as a violation of the state’s Taxpayer’s Bill of Rights.” Long story short, Norris says? SB2 seems like it might be a waste of time.
Are medical homes saving money?
At Population Health Blog, Jaan Sidorov looks at patient-centered medical homes (PCMH) in his post, An Update on the Evidence of the Impact of the Patient Centered Medical Home on Cost and Quality: Of Soup and Weather Vanes. In the post, Sidorov reviews the latest findings on the impact of a reorganized version of primary care dubbed the “medical home.”
According to the medical home’s trade association, the latest science on the topic shows evidence of savings, lower utilization and increased quality. According to Sidorov, the findings vary considerably, but that doesn’t bother him. He says the organization of the medical home is “more like a adaptable ‘soup’ recipe and that the evidence has more to do with the directionality of a weather vane than any scientific precision.'”
It’s not about the money, money, money
Sadly, not all of this week’s posts fit my theme. Here’s were we missed:
- If money doesn’t change everything, how about connectivity? In Oh, The Problems Connectivity Can Solve!, Peggy Salvatore expounds on the various permutations of hyperconnectivity and how – done well – it can eventually solve cost, access and quality issues in healthcare.
- Over at Healthcare Economist, Jason Shafrin summarizes his most recent research examining how well outcomes in clinical trials translate into real-world outcomes among patients receiving cancer treatments. Check out The value of surrogate endpoints for predicting real-world survival across five cancer types.
Special recognition to Henry Stern for this week’s chuckle: In Finally! Free male cancer screening, Stern notes that “prostate cancer screening’s important, but the ACA doesn’t consider it preventive care.” Luckily, as InsureBlog reports, some other federal agency does. There’s a twist, though … and you’ll have to read it for yourself.
That’s it for this week’s edition of Health Wonk Review. Tune in next time – on February 25 – as Louise Norris hosts HWR over at Colorado Health Insurance Insider.